Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Brazil diabetes care devices market was valued at USD 15.50 Billion in 2025 and is expected to grow at a CAGR of 9.60%, reaching USD 38.76 Billion by 2035. The market growth is driven by the rising prevalence of diabetes, increasing healthcare investments, and growing awareness regarding diabetes management. The adoption of glucose monitoring devices and expansion of healthcare services are expected to contribute to market growth during the forecast period.
Compound Annual Growth Rate
9.6%
Value in USD Billion
2026-2035
Read more about this report - Request a Free Sample
Diabetes care devices are becoming increasingly accessible through technological innovation and improved healthcare services, supporting more effective disease monitoring and treatment. These advancements contribute to better patient outcomes. The market is supported by expanding healthcare coverage and growing awareness of diabetes management. The market is poised to grow at a CAGR of 9.60% during the forecast period of 2026-2035 due to increasing adoption of modern medical devices and continuous healthcare investments.
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
Rising diabetes prevalence is accelerating market expansion. |
More than 16.5 million Brazilians have diabetes, while over five million remain undiagnosed, increasing demand for diabetes care devices. |
|
Market Restraints |
High cost of advanced diabetes care devices limits market growth. |
High prices of continuous glucose monitoring systems and insulin delivery devices reduce affordability and limit adoption across underserved regions. |
|
Market Opportunities |
Expanding access to advanced diabetes therapies is creating new market potential. |
In April 2024, Biocon Limited partnered with Biomm S.A. to commercialize semaglutide, improving access to advanced diabetes treatment in Brazil. |
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.
Rising Diabetes Prevalence is Accelerating Market Expansion
The market is expanding steadily due to the rising prevalence of diabetes and the increasing need for effective disease monitoring and insulin management solutions. A growing patient population, including individuals with undiagnosed diabetes, is driving demand for blood glucose monitoring systems, insulin delivery devices, and digital diabetes management technologies. According to Sandoz, more than 16.5 million people in Brazil are living with diabetes, while over five million remain undiagnosed, highlighting the need for improved diagnosis and long-term disease management. This growing disease burden is expected to strengthen demand for advanced diabetes care devices and support sustained market expansion.
High Cost of Advanced Diabetes Care Devices Limits Market Value
The high cost of advanced diabetes care devices, particularly continuous glucose monitoring systems and insulin delivery technologies, remains a significant challenge for the market. Limited affordability, combined with unequal healthcare access across different regions, restricts the adoption of innovative diabetes management solutions. Ensuring equitable access to essential diabetes care remains a global healthcare priority, indicating that affordability barriers continue to limit broader device adoption and market expansion.
Expanding Access to Advanced Diabetes Therapies is Creating New Market Potential
The increasing availability of innovative diabetes therapies and strategic collaborations is creating favorable conditions for the market. Partnerships that improve access to advanced treatments encourage greater adoption of compatible drug delivery devices and diabetes management solutions. For example, in April 2024, Biocon Limited entered into an exclusive agreement with Biomm S.A. to commercialize semaglutide in Brazil, expanding access to advanced diabetes treatment. Such collaborations are expected to strengthen the diabetes care ecosystem and create long-term opportunities for market development.
The market is witnessing several trends, including advanced drug delivery technologies, connected diabetes care, and patient-centric treatment solutions.
Growing Adoption of Patient-Centric Drug Delivery Technologies is Enhancing Market Growth
The market is increasingly shifting toward patient-friendly drug delivery technologies that improve treatment adherence and self-administration. For example, in July 2026, BD and EMS collaborated to launch semaglutide in Brazil using an advanced injection pen platform designed for accurate and convenient self-injection. This reflects the growing emphasis on integrated drug-device solutions, which is expected to improve patient outcomes and support continued market growth.
Read more about this report - Request a Free Sample
Blood Glucose Monitoring Systems are Expected to Lead Market Share by Product Type
The market is segmented into blood glucose monitoring systems, insulin delivery devices, diabetes management mobile applications. Among these, blood glucose monitoring systems are expected to hold the leading position owing to the increasing demand for continuous and accurate glucose monitoring for effective diabetes management. For example, in March 2026, Glucotrack highlighted the successful completion of its Brazilian clinical study for its implantable continuous blood glucose monitoring technology, demonstrating strong safety and accuracy outcomes. Such technological advancements are expected to accelerate the adoption of advanced glucose monitoring solutions and strengthen the market over the forecast period.
The key features of the market report include funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:
Bionime Corporation specializes in blood glucose management systems for personal and professional use. Its portfolio includes blood glucose meters, continuous glucose monitoring device, point-of-care testing devices, and the RIGHTEST cloud-based platform. Through its advanced diabetes monitoring technologies, the company supports the market by enabling accurate glucose management and digital diabetes care solutions.
Novo Nordisk A/S is a global healthcare company that develops innovative diabetes care solutions. Its product portfolio includes NovoPen® 4, NovoPen® 5, NovoPen Echo®, FlexPen®, FlexTouch®, and smart insulin pens such as NovoPen® 6 and NovoPen Echo® Plus. Through its advanced insulin delivery devices, the company strengthens the market by improving treatment accuracy and patient convenience.
Medtronic plc is a leading medical technology company offering advanced diabetes management devices. Its portfolio includes the MiniMed™ 780G automated insulin pump system, MiniMed Go™ smart insulin management platform, and InPen™ Smart Insulin Pen integrated with continuous glucose monitoring technologies. These innovative insulin delivery and monitoring solutions support the Brazil diabetes care devices market by enhancing glycemic control and simplifying diabetes management.
Insulet Corporation develops innovative insulin delivery technologies through its Omnipod® platform. In February 2026, the company launched the Omnipod® 5 Automated Insulin Delivery System and Omnipod Discover™ data management platform in the Middle East, expanding global access to advanced diabetes care. Its wearable, tubeless insulin delivery solutions reinforce its presence in the Brazil diabetes care devices market through innovative diabetes management technologies.
Other key players in the market include Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Becton, Dickinson and Company, DexCom, Inc., Eli Lilly and Company, and F. Hoffmann-La Roche AG.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
The market is segmented by product type, driven by increasing healthcare investments, rising awareness of diabetes management, and expanding adoption of advanced technologies designed to improve patient care and treatment outcomes.
Market Breakup by Disease Type
The market is segmented by disease type, supported by increasing diabetes prevalence, greater emphasis on early diagnosis, and expanding access to effective disease management solutions across the country.
Market Breakup by Patient Care Settings
The market is segmented by patient care settings, reflecting growing demand for comprehensive diabetes care, improving healthcare accessibility, and increasing utilization of modern healthcare delivery models.
This report is developed through a robust mixed-methods research approach combining primary and secondary research with comprehensive data validation.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Disease Type |
|
| Breakup by Patient Care Settings |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.